Aspirin inhibits expression of the interleukin-1β-inducible group II phospholipase A2

FEBS Letters

Volumn 397, Issue 1, 1996, Pages 108-112

  Vervoordeldonk, Margriet J B M ^a   Pineda Torra, Inés M ^a   Aarsman, Anton J ^a   Van Den Bosch, Henk ^a  

^a Institute of Biomembranes   (Netherlands)

Author keywords

Aspirin; Interleukin 1 ; NF B; Phospholipase A2; Rat mesnagial cell

Indexed keywords

ACETYLSALICYLIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MESSENGER RNA; PHOSPHOLIPASE A2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DNA BINDING; DOSE RESPONSE; ELECTROPHORETIC MOBILITY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE EXPRESSION; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELLS, CULTURED; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INDUCTION; GLOMERULAR MESANGIUM; INTERLEUKIN-1; NF-KAPPA B; PHOSPHOLIPASES A; RATS; RNA, MESSENGER;

ANIMALIA;

EID: 0030580367     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-5793(96)01148-9     Document Type: Article

References (39)

1. [1] Chang, H.W., Kudo, I., Tomita, H. and Inoue, K. (1987) J. Biochem. 102, 147-159.
2. [2] Seilhamer, J.J., Pruzanski, W., Vadas, P., Plant, S., Meller, J.A., Klost, J. and Johnson, L.K. (1989) J. Biol. Chem. 264, 5335-5338.
3. [3] Kara, S., Kudo, I., Matsuta, K., Miyamoto, T. and Inoue, K. (1988) J. Biochem. 104, 326-328.
4. [4] Pruzanski, W. and Vadas, P. (1991) Immunol. Today 12, 143-146.
5. [5] Brooks, P.M. and Day, R.O. (1991) New Engl. J. Med. 324, 1716-1725.
6. [6] Vane, J.R. (1971) Nature New Biol. 231, 232-235.
7. [7] Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flower, R.J. and Vane, J.R. (1993) Proc. Nat. Acad. Sci. USA 90, 11693-11697.
8. [8] Meade, E.A., Smith, W.L. and DeWitt, D.L. (1993) J. Biol. Chem. 268, 6610-6614.
9. [9] Xie, W., Robertson, D.L. and Simmons, D.L. (1992) Drug Dev. Res. 25, 249-265.
10. [10] Humus, J.L., Winter, C.A., Sadowski, S.J. and Kuehl, F.A. (1981) Proc. Natl. Acad. Sci. USA 78, 2053-2056.
11. [11] Pederson, A.K. and Fritzgerald, G.A. (1984) New Engl. J. Med, 311, 1206-1211.
12. [12] Higgs, G.A., Harvey, E.A., Ferreira, S.H. and Vane, J.R. (1976) in: Advances in Prostaglandin and Thromboxane Research (Samuelsson, B. and Paoletti, R., Eds.), Vol. 1, pp. 105-110, Raven, New York.
13. [13] Flower, R.J., Macada, S. and Vane, J.R. (1980) in: The Pharmacological Basis of Therapeutics (Goodman, A.G. and Gilman, L.H., Eds.), Vol. 6, pp. 682-698, MacMillan, New York.
14. [14] Weismann, G. (1991) Sci. Am. 264, 58-64.
15. [15] Vargaftig, B. and Lefort, J. (1977) Eur. J. Pharmacol. 43, 125-141.
16. [16] Kopp, E. and Gosh, S. (1994) Science 265, 956-959.
17. [17] Grilli, M., Chiu, J-S. and Lenardo, M.J. (1993) Int. Rev. Cytol. 143, 1-62.
18. [18] Pfeilschifter, J., Pignat, W., Vosbeck, K. and Märki, F. (1989) Biochem. Biophys. Res. Commun. 159, 385-394.
19. [19] Schalkwijk, C.G., Pfeilschifter, J., Märki, F. and van den Bosch, H. (1991) Biochem. Biophys. Res. Commun. 174, 268-275.
20. [20] Mühl, H., Geiger, T., Pignat, W., Märki, F., van den Bosch, H., Vosbeck, K. and Pfeilschifter, J. (1991) FEBS Lett. 291, 249-252.
21. [21] Vervoordeldonk, M.J.B.M., Schalkwijk, C.G., Pfeilschifter, J. and van den Bosch, H. (1996) Biochem. J. 315, 435-441.
22. [22] Walker, G., Kunz, D., Pignat, W., van den Bosch, H. and Pfeilschifter, J. (1995) FEBS Lett. 364, 218-222.
23. [23] Pfeilschifter, J., Kurtz, A. and Bauer, C. (1984) Biochem. J. 223, 855-859.
24. [24] Abramson, S., Korchak, H., Ludewig, R., Edelson, H., Haines, K., Levin, R.I., Herman, R., Rider, L., Kimmel, S. and Weissmann, G. (1985) Proc. Nat. Acad. Sci. USA 82, 7227-7231.
25. [25] Van den Bosch, H., Aarsman, A.J. and van Deenen, L.L.M. (1974) Biochim. Biophys. Acta 348, 197-207.
26. [26] Angeletti, B., Battiloro, E., Pascale, E. and D'Ambrosio, E. (1995) Nucleic Acids Res. 23, 879-880.
27. [27] Wilkinson, M., Doskow, J. and Lindsey, S. (1991) Nucleic Acids Res. 19, 679.
28. [28] Moldeus, P., Hogberg, J. and Orrenius, S. (1978) in: Methods in Enzymology (Jakoby, W.B., Ed.), pp. 60-71, Academic Press, New York.
29. [29] Dignam, D., Lebovitz, R.M. and Roerder, R.G. (1983) Nucleic Acids Res. 11, 1475-1489.
30. [30] Schreiber, E., Matthias, P., Müller, M.M. and Schaffner, W. (1989) Nucleic Acids Res. 17, 6419.
31. [31] Tetsuka, T., Srivastava, S.K. and Morrison, A.R. (1996) Biochem. Biophys. Res. Commun. 218, 808-812.
32. [32] Bradford, M. (1976) Anal. Biochem. 72, 248-254.
33. [33] Andrieu, N., Salvayre, R., Jaffrézou, J.-P. and Levade T. (1995) Biochem. Biophys. Res. Commun. 218, 808-812.
34. [34] Wu, K.K., Sanduja, R., Tsai, A.L., Ferhanoglu, B. and Loose-Mitchell, D.S. (1991) Proc. Natl. Acad. Sci. USA 88, 2384-2387.
35. [35] Kunz, D., Walker, G., Eberhardt, W., Nitsch, D. and Pfeilschifter, J. (1995) Biochem. Biophys. Res. Commun. 216, 438-446.
36. [36] Lobo, I.B. and Hpult, J.R.S. (1994) Agents Actions 41, 111-113.
37. [37] Famaey, J.P. and Paulus, H.E. (Eds.) (1992) Therapeutic Applications of NSAID Subpopulations and New Formulations, Dekker. New York.
38. [38] Palmoski, M.J. and Brandt. K.D. (1984) Arthritis Rheum. 27, 398-402.
39. [39] Amin, A.R., Vyas, P., Attur, M., Leszczynska-Piziak, J., Patel, I.R., Weismann, G. and Abramson, S.B. (1995) Proc. Nat. Acad. Sci. USA 92, 7926-7930.